Get ready for the next wave of pharmaceutical and medical device litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
Download a publication order form here or subscribe here.
Drugs & Medical Devices - Issue: 18
Canadian Plaintiffs Granted Access to Documents Already Produced in Baycol MDL
First Nationwide Class Action on Behalf of All Ephedra Users Filed Against Supplement Makers
Six Cases Involving OxyContin-Related Injuries Dismissed in State and Federal Courts
Drugs & Medical Devices - Issue: 17
Antipsychotic Can Allegedly Cause Patients to Develop Diabetes
Canadian Researchers Find Patients Using Remicade Have Greater Risk of Tuberculosis
CMO Bank - Baycol/Meridia/PPA/Propulsid - May 2003
CMO Bank - Rezulin/Serzone - May 2003
Journal Watch - May 2003
